Letter from the Editor: Guarded Optimism - Takeaways - MDSpire

Letter from the Editor: Guarded Optimism

We’ve come out of a year that showed solid growth for many ASCs, and—in no small part due to the hard work of OOSS leadership—we will enjoy another increase in cataract surgical fee reimbursement this year.

  • By

  • Mark A. Kontos, MD, Co-Chief Medical Editor

  • March 1, 2026

  • 2 min

Share

  • 1

    The ophthalmic ASC landscape appears promising as we approach 2026, with solid growth and increased cataract surgical fee reimbursement.

  • 2

    The ASC patient experience remains highly rated, indicating strong satisfaction among patients undergoing ophthalmic procedures.

  • 3

    Challenges such as rising operational costs and staffing shortages may impact the financial health of ASCs in the coming year.

  • 4

    The potential growth of office-based surgery could pose competitive risks for lesser-known ASCs in the ophthalmic field.

  • 5

    OOSS and The Ophthalmic ASC will continue to advocate for ASCs, ensuring they remain informed and supported amid upcoming challenges.

Original Source(s)

Letter from the Editor: Guarded Optimism

  • by Mark A. Kontos, MD, Co-Chief Medical Editor

  • March 1, 2026

Related Content

Bag-in-the-lens technique

Thirty Years Together in a Career Defined by Change

Progress begins when we accept that the only certainty is uncertainty.

Success and Failure Rates with Increased-Range-of-Focus IOLs 

IRoF lenses offer high success, with some outperforming others